Massachusetts Financial Services’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-81,037
| Closed | -$2.52M | – | 903 |
|
|
2021
Q4 | $2.52M | Sell |
81,037
-1,642
| -2% | -$51K | ﹤0.01% | 755 |
|
|
2021
Q3 | $2.01M | Sell |
82,679
-17,062
| -17% | -$414K | ﹤0.01% | 783 |
|
|
2021
Q2 | $1.46M | Buy |
99,741
+856
| +0.9% | +$12.5K | ﹤0.01% | 811 |
|
|
2021
Q1 | $2.47M | Sell |
98,885
-11,719
| -11% | -$293K | ﹤0.01% | 743 |
|
|
2020
Q4 | $3.02M | Sell |
110,604
-1,108
| -1% | -$30.2K | ﹤0.01% | 699 |
|
|
2020
Q3 | $2.06M | Sell |
111,712
-4,377
| -4% | -$80.8K | ﹤0.01% | 713 |
|
|
2020
Q2 | $2.37M | Buy |
116,089
+27,664
| +31% | +$565K | ﹤0.01% | 673 |
|
|
2020
Q1 | $1.29M | Buy |
88,425
+13,995
| +19% | +$204K | ﹤0.01% | 716 |
|
|
2019
Q4 | $1.06M | Buy |
74,430
+17,587
| +31% | +$250K | ﹤0.01% | 756 |
|
|
2019
Q3 | $658K | Buy |
+56,843
| New | +$658K | ﹤0.01% | 787 |
|